Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 110751-110800 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03393832
Oral Care in Infants With Gastroschisis
N/AActive, not recruiting
27 participants
Started: Oct 14, 2017 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03121456
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
NAActive, not recruiting
74 participants
Started: Oct 13, 2017 · Completed: Apr 12, 2024
1 condition1 sponsor1 location
NCT03223779
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
52 participants
Started: Oct 13, 2017 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT03281369
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
PHASE1/PHASE2Active, not recruiting
410 participants
Started: Oct 13, 2017 · Completed: Nov 30, 2025
1 condition3 sponsors27 locations
NCT03233347
Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
PHASE2Active, not recruiting
82 participants
Started: Oct 13, 2017 · Completed: Jul 8, 2026
7 conditions2 sponsors9 locations
NCT03303846
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
NAActive, not recruiting
344 participants
Started: Oct 13, 2017 · Completed: Apr 25, 2026
1 condition2 sponsors5 locations
NCT03168776
PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease
NAActive, not recruiting
1,632 participants
Started: Oct 13, 2017 · Completed: Sep 30, 2024
1 condition2 sponsors58 locations
NCT02759744
Fusion Guided Focal Laser Ablation of Prostate Cancer
NAEnrolling by invitation
30 participants
Started: Oct 13, 2017 · Completed: Jan 21, 2027
2 conditions1 sponsor1 location
NCT03141619
Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2
N/ARecruiting
500 participants
Started: Oct 13, 2017 · Completed: Jun 30, 2025
4 conditions8 sponsors1 location
NCT02966756
A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PHASE2Recruiting
110 participants
Started: Oct 12, 2017 · Completed: May 31, 2029
2 conditions1 sponsor31 locations
NCT03958773
Cardiovalve Transfemoral System - FIM Study
NARecruiting
10 participants
Started: Oct 12, 2017 · Completed: Oct 30, 2026
1 condition2 sponsors1 location
NCT03019406
A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa
PHASE2Active, not recruiting
22 participants
Started: Oct 12, 2017 · Completed: Dec 30, 2026
1 condition1 sponsor12 locations
NCT05930899
Translational-Omics in Aortic Stenosis (TOmAS) Biobank
N/ARecruiting
10,000 participants
Started: Oct 12, 2017 · Completed: Jan 1, 2040
2 conditions1 sponsor2 locations
NCT03288545
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
PHASE1/PHASE2Active, not recruiting
348 participants
Started: Oct 11, 2017 · Completed: Sep 11, 2026
7 conditions3 sponsors106 locations
NCT04275167
Capsule Endomicroscopy for Visualization of the Small Intestine in EED Population in Pakistan
NAEnrolling by invitation
170 participants
Started: Oct 11, 2017 · Completed: Jan 31, 2029
1 condition3 sponsors1 location
NCT03148327
Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy
PHASE1/PHASE2Active, not recruiting
18 participants
Started: Oct 11, 2017 · Completed: Jun 1, 2027
1 condition2 sponsors4 locations
NCT03225144
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
N/ARecruiting
360 participants
Started: Oct 11, 2017 · Completed: Oct 30, 2027
3 conditions1 sponsor1 location
NCT03213275
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury
N/AActive, not recruiting
60 participants
Started: Oct 11, 2017 · Completed: Sep 28, 2026
3 conditions2 sponsors1 location
NCT05222854
"Comprehensive Genomic Profiling Combined With Real Life Data of The German-Registry of Incidental Gallbladder Carcinoma"
N/AActive, not recruiting
200 participants
Started: Oct 11, 2017 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT03298451
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
PHASE3Active, not recruiting
1,324 participants
Started: Oct 11, 2017 · Completed: Aug 27, 2026
1 condition1 sponsor160 locations
NCT03206060
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
PHASE2Recruiting
130 participants
Started: Oct 10, 2017 · Completed: Jan 1, 2027
4 conditions1 sponsor1 location
NCT04504006
European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III
N/ARecruiting
500 participants
Started: Oct 10, 2017 · Completed: Jan 1, 2030
1 condition1 sponsor1 location
NCT03471403
Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
N/ARecruiting
100 participants
Started: Oct 10, 2017 · Completed: Oct 10, 2028
1 condition1 sponsor1 location
NCT02856893
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
PHASE2Active, not recruiting
156 participants
Started: Oct 10, 2017 · Completed: Dec 31, 2027
1 condition2 sponsors22 locations
NCT03268603
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
PHASE2Active, not recruiting
75 participants
Started: Oct 10, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors3 locations
NCT03315910
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
PHASE4Active, not recruiting
807 participants
Started: Oct 10, 2017 · Completed: Oct 31, 2026
1 condition2 sponsors18 locations
NCT03129139
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
PHASE1Recruiting
66 participants
Started: Oct 10, 2017 · Completed: Dec 1, 2024
10 conditions2 sponsors7 locations
NCT03299530
Accuracy of Corneal Astigmatism in Different Region Modes
N/ARecruiting
70 participants
Started: Oct 10, 2017 · Completed: Oct 28, 2026
2 conditions1 sponsor1 location
NCT03188796
The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients
PHASE3Recruiting
2,400 participants
Started: Oct 10, 2017 · Completed: Mar 31, 2027
3 conditions35 sponsors18 locations
NCT03365908
Pain Management of ACL Reconstruction
NAEnrolling by invitation
60 participants
Started: Oct 9, 2017 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT03211663
Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
N/AActive, not recruiting
269 participants
Started: Oct 9, 2017 · Completed: Dec 1, 2025
3 conditions1 sponsor5 locations
NCT06160960
Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
N/ARecruiting
500 participants
Started: Oct 9, 2017 · Completed: Oct 1, 2024
3 conditions2 sponsors1 location
NCT03319446
Collection of Anonymized Samples
N/AEnrolling by invitation
1,500 participants
Started: Oct 9, 2017 · Completed: Oct 31, 2027
3 conditions1 sponsor1 location
NCT04747847
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
EARLY_PHASE1Active, not recruiting
10 participants
Started: Oct 9, 2017 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT03330132
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong
PHASE4Active, not recruiting
1,861 participants
Started: Oct 7, 2017 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03500133
Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.
PHASE4Recruiting
500 participants
Started: Oct 6, 2017 · Completed: Oct 31, 2032
1 condition1 sponsor1 location
NCT03270059
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
PHASE2Recruiting
150 participants
Started: Oct 6, 2017 · Completed: Aug 15, 2027
3 conditions3 sponsors1 location
NCT03357120
Circulating Tumor DNA After Neoadjuvant Chemotherapy
NARecruiting
180 participants
Started: Oct 6, 2017 · Completed: Oct 31, 2028
1 condition2 sponsors1 location
NCT03308916
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NARecruiting
6,500 participants
Started: Oct 6, 2017 · Completed: Oct 30, 2035
2 conditions16 sponsors1 location
NCT03331744
Clinical Characteristics of Infantile Hemangioma
N/ARecruiting
1,000 participants
Started: Oct 6, 2017 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT03161808
Rare CFTR Mutation Cell Collection Protocol (RARE)
N/ARecruiting
500 participants
Started: Oct 5, 2017 · Completed: Dec 1, 2026
1 condition2 sponsors6 locations
NCT04855825
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
NARecruiting
10 participants
Started: Oct 5, 2017 · Completed: Dec 30, 2025
4 conditions2 sponsors1 location
NCT03240328
The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
PHASE1Recruiting
40 participants
Started: Oct 4, 2017 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT03014167
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
PHASE3Active, not recruiting
502,363 participants
Started: Oct 4, 2017 · Completed: May 31, 2024
2 conditions10 sponsors3 locations
NCT03275051
Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)
NAActive, not recruiting
9 participants
Started: Oct 4, 2017 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT03209102
Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder
PHASE2Active, not recruiting
66 participants
Started: Oct 4, 2017 · Completed: Jan 3, 2026
2 conditions1 sponsor1 location
NCT03307616
Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery
PHASE2Active, not recruiting
32 participants
Started: Oct 4, 2017 · Completed: Oct 31, 2027
6 conditions2 sponsors1 location
NCT03750266
3D Animation and Models to Aid Management of Fetal CDH
N/ARecruiting
30 participants
Started: Oct 4, 2017 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03214510
Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery
PHASE3Recruiting
96 participants
Started: Oct 4, 2017 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT03319082
Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery
N/ARecruiting
200 participants
Started: Oct 4, 2017 · Completed: Feb 28, 2026
1 condition1 sponsor11 locations